Format

Send to

Choose Destination
See comment in PubMed Commons below
Radiology. 2000 Jan;214(1):29-38.

Tamoxifen-induced uterine abnormalities: the role of imaging.

Author information

1
Department of Radiology, Georgetown University Medical Center, Washington, DC 20007-2197, USA. aschers@gunet.georgetown.edu

Abstract

Tamoxifen citrate is an orally administered, nonsteroidal antiestrogen agent that is widely used for the treatment of breast cancer and that has recently been found to prevent breast cancer in some high-risk populations. Tamoxifen may, however, cause adverse effects at the uterine level. In this article, the authors review (a) the histopathologic uterine changes associated with tamoxifen therapy, (b) the spectrum of uterine imaging findings in women treated with tamoxifen, and (c) the recommendations of the American College of Obstetrics and Gynecology for women treated with tamoxifen. An algorithm for imaging evaluation of the uterus in women treated with tamoxifen is presented.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center